Back to top
more

LeMaitre Vascular (LMAT)

(Real Time Quote from BATS)

$102.40 USD

102.40
141,424

+3.77 (3.82%)

Updated Nov 6, 2024 03:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Balance Sheet

Research for LMAT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for LeMaitre Vascular, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 105 83 70 27 33
Receivables 25 22 20 20 17
Notes Receivable 0 0 0 0 0
Inventories 58 50 46 45 40
Other Current Assets 6 7 4 3 3
Total Current Assets 195 162 140 94 92
Net Property & Equipment 22 18 17 15 15
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 1 2 2 2 1
Intangibles 108 112 119 125 65
Deposits & Other Assets 4 1 1 1 0
Total Assets 347 310 293 253 188
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 4 3 2 2 3
Current Portion Long-Term Debt 0 0 0 3 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 24 20 16 18 14
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 1 1 1 2
Total Current Liabilities 30 25 22 25 21
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 1
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 36 14
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 2 2 3 5 4
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 49 42 39 80 40
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 201 189 182 115 106
Retained Earnings 115 98 88 71 57
Other Equity -5 -6 -3 -2 -4
Treasury Stock 14 13 12 12 11
Total Shareholder's Equity 298 268 254 173 148
Total Liabilities & Shareholder's Equity 347 310 293 253 188
Total Common Equity 298 268 254 173 148
Shares Outstanding 22.20 22.00 21.80 20.30 19.90
Book Value Per Share 13.42 12.19 11.66 8.50 7.44

Fiscal Year End for LeMaitre Vascular, Inc falls in the month of December.

All items in Millions except Per Share data.

9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Assets          
Cash & Equivalents 124 113 108 105 97
Receivables 32 31 30 25 24
Notes Receivable NA 0 0 0 0
Inventories 65 64 61 58 56
Other Current Assets 6 5 4 6 5
Total Current Assets 227 213 203 195 182
Net Property & Equipment 24 23 22 22 21
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges 1 1 1 1 2
Intangibles 103 105 106 108 109
Deposits & Other Assets 4 4 4 4 3
Total Assets 377 363 354 347 334
Liabilities & Shareholders Equity 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable 2 2 3 4 4
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses 23 21 21 24 22
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities 1 0 0 0 0
Total Current Liabilities 29 25 27 30 29
Mortgages NA 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities 1 2 2 2
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities 46 44 45 49 45
Shareholders Equity 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 211 209 206 201 198
Retained Earnings 138 130 122 115 110
Other Equity -3 -5 -6 -5 -7
Treasury Stock 14 14 14 14 13
Total Shareholder's Equity 331 320 309 298 289
Total Liabilities & Shareholder's Equity 377 363 354 347 334
Total Common Equity 100,330 320 309 298 289
Shares Outstanding 22.40 22.40 22.40 22.20 22.20
Book Value Per Share 4,479.02 14.26 13.77 13.42 13.00